Release Summary

Alexion announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Kanuma® (sebelipase alfa) for the treatment of patients of all ages in Japan with LAL-D.

Alexion Pharmaceuticals, Inc.